Satjit S Brar

age ~50

from San Diego, CA

Get Report
Also known as:
  • Satjit F Brar
  • Atjit Brar
Phone and address:
9976 Fox Meadow Rd, San Diego, CA 92127
8585218718
Related to:
Connected to:

Satjit Brar Phones & Addresses

  • 9976 Fox Meadow Rd, San Diego, CA 92127 • 8585218718
  • 26261 Glen Canyon Dr, Laguna Hills, CA 92653 • 9493067306
  • Silver Spring, MD
  • Richmond, VA
  • Santa Barbara, CA

Work

  • Company:
    Fda
    May 2011
  • Position:
    Reviewer

Education

  • Degree:
    Ph.D.
  • School / High School:
    Virginia Commonwealth University
    2000 to 2008
  • Specialities:
    Pharmacokinetics/Pharmacodynamics

Skills

Clinical Pharmacology • Pharmacology • Pharmacokinetics • Clinical Trials • Drug Development • Drug Discovery • Clinical Development • Clinical Research • Regulatory Affairs • Pharmacodynamics • Toxicology • Neuroscience • Clinical Study Design • Biotechnology • Translational Research • Biomarkers • Translational Medicine • Animal Models • Drug Metabolism • Science • Adme • Oncology

Industries

Research

Resumes

Satjit Brar Photo 1

Executive Director

view source
Location:
Silver Spring, MD
Industry:
Research
Work:
FDA since May 2011
Reviewer
FDA Dec 2008 - May 2011
Post-doctoral Research Fellow
Virginia Commonwealth University May 2008 - Dec 2008
Post-doctoral Fellow
Education:
Virginia Commonwealth University 2000 - 2008
Ph.D., Pharmacokinetics/Pharmacodynamics Virginia Commonwealth University 2000 - 2008
Pharm.D., Pharmacy University of California, Santa Barbara 1995 - 1998
Skills:
Clinical Pharmacology
Pharmacology
Pharmacokinetics
Clinical Trials
Drug Development
Drug Discovery
Clinical Development
Clinical Research
Regulatory Affairs
Pharmacodynamics
Toxicology
Neuroscience
Clinical Study Design
Biotechnology
Translational Research
Biomarkers
Translational Medicine
Animal Models
Drug Metabolism
Science
Adme
Oncology

Us Patents

  • Dosing Regimen Of Avelumab For The Treatment Of Cancer

    view source
  • US Patent:
    20190330352, Oct 31, 2019
  • Filed:
    Oct 5, 2017
  • Appl. No.:
    16/339779
  • Inventors:
    - New York NY, US
    - Darmstadt, DE
    Satjit Singh BRAR - San Diego CA, US
    Shaonan WANG - Muehltal Traisa, DE
    Pascal GIRARD - Renens, CH
  • Assignee:
    PFIZER INC - New York NY
    MERCK PATENT GmbH - Darmstadt
  • International Classification:
    C07K 16/28
    A61P 35/00
  • Abstract:
    The present invention relates to dosing regimen of avelumab for the treatment of cancer. In particular, the invention relates to improved dosing regimen of avelumab for the treatment of cancer.

  • Pd-1/Pd-L1 Inhibitors For Cancer Treatment

    view source
  • US Patent:
    20190144545, May 16, 2019
  • Filed:
    May 22, 2017
  • Appl. No.:
    16/304338
  • Inventors:
    - Darmstadt, DE
    - New York NY, US
    Adrian WOOLFSON - Brooklyn NY, US
    Aron THALL - San Diego CA, US
    Kevin CHIN - Sudbury MA, US
    Satjit BRAR - San Diego CA, US
  • Assignee:
    MERCK PATENT GMBH - Darmstadt
    PFIZER INC. - New York NY
  • International Classification:
    C07K 16/28
    A61P 35/04
  • Abstract:
    The invention relates to methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an inhibitor of the interaction between the PD-1 receptor and its ligand PD-L1.
Get Report for Satjit S Brar from San Diego, CA, age ~50
Control profile